UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

The Journal of immunology (1950), 2017-05, Vol.198 (10), p.4012-4024

2017

Volltextzugriff (PDF)

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Frontiers in immunology, 2020-04, Vol.11, p.592-592

2020

Volltextzugriff (PDF)

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

The Lancet infectious diseases, 2015-05, Vol.15 (5), p.519-527

2015

Volltextzugriff (PDF)

Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya

Expert review of vaccines, 2019-04, Vol.18 (4), p.393-403

2019

Volltextzugriff (PDF)

Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1

Molecular and Cellular Biology, 2006-11, Vol.26 (21), p.7913-7928

2006

Volltextzugriff (PDF)

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study

EBioMedicine, 2022-01, Vol.75, p.103810-103810, Article 103810

2022

Volltextzugriff (PDF)

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

EBioMedicine, 2022-01, Vol.75, p.103811-103811, Article 103811

2022

Volltextzugriff (PDF)

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (8), p.2849-2854

2007

Volltextzugriff (PDF)

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine

JCI insight, 2021-11, Vol.6 (21)

2021

Volltextzugriff (PDF)

Chikungunya Virus Vaccines: Viral Vector–Based Approaches: Table 1

The Journal of infectious diseases, 2016-12, Vol.214 (suppl 5), p.S500-S505

2016

Volltextzugriff (PDF)

p38 MAPK Enhances STAT1-Dependent Transcription Independently of Ser-727 Phosphorylation

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (20), p.12859-12864

2002

Volltextzugriff (PDF)

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

The Lancet (British edition), 2018-12, Vol.392 (10165), p.2718-2727

2018

Volltextzugriff (PDF)

Chikungunya Virus Vaccines: Viral Vector–Based Approaches

The Journal of infectious diseases, 2016-12, Vol.214 (suppl 5), p.S500-S505

2016

Volltextzugriff (PDF)

Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons

EMBO reports, 2003-04, Vol.4 (4), p.368-373

2003

Volltextzugriff (PDF)

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

The Lancet (British edition), 2023-04, Vol.401 (10384), p.1267-1276

2023

Volltextzugriff (PDF)

Biodistribution and toxicology evaluation of a recombinant measles Schwarz‐based Lassa vaccine in cynomolgus macaques

Journal of applied toxicology, 2023-05, Vol.43 (5), p.719-733

2023

Volltextzugriff (PDF)

Immunogenicity, safety and tolerability of a recombinant measles-vectored Lassa vaccine: A randomised, placebo-controlled, first-in-human trial

The Lancet (British edition), 2023-04, Vol.401 (10384), p.1267-1276

2023

Volltextzugriff (PDF)

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

The Journal of infectious diseases, 2019-07, Vol.220 (5), p.735-742

2019

Volltextzugriff (PDF)

A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial

Vaccine, 2023-10, Vol.41 (43), p.6495-6504

2023

Volltextzugriff (PDF)

Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-γ-Dependent Innate Immunity

Immunity (Cambridge, Mass.), 2003-12, Vol.19 (6), p.793-802

2003

Volltextzugriff (PDF)

Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression

The EMBO journal, 2001-01, Vol.20 (1-2), p.91-100

2001

Volltextzugriff (PDF)

A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding

The Journal of immunology (1950), 2011-04, Vol.186 (7), p.4213-4222

2011

Volltextzugriff (PDF)

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-[gamma]-inducible gbp2 gene

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (8), p.2849

2007

Volltextzugriff (PDF)

The Stat1 Binding Motif of the Interferon-γ Receptor Is Sufficient to Mediate Stat5 Activation and Its Repression by SOCS3

The Journal of biological chemistry, 2001-12, Vol.276 (49), p.45722-45728

2001

Volltextzugriff (PDF)

Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-[gamma]-Dependent Innate Immunity

Immunity (Cambridge, Mass.), 2003-12, Vol.19 (6), p.793

2003

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Humans
(15)
Animals
(14)
Immunology
(11)
Mice
(9)
Vaccines
(9)
Female
(7)
Viral Vaccines - Immunology
(7)
Chikungunya Fever - Prevention & Control
(6)
Male
(6)
Measles
(6)
Phosphorylation
(6)
Adult
(5)
Antibodies
(5)
Chikungunya Virus
(5)
Chikungunya Virus - Immunology
(5)
Dna-Binding Proteins - Metabolism
(5)
Double-Blind Method
(5)
Medicine, Research & Experimental
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya

Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine

Chikungunya Virus Vaccines: Viral Vector–Based Approaches: Table 1

p38 MAPK Enhances STAT1-Dependent Transcription Independently of Ser-727 Phosphorylation

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Chikungunya Virus Vaccines: Viral Vector–Based Approaches

Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

Biodistribution and toxicology evaluation of a recombinant measles Schwarz‐based Lassa vaccine in cynomolgus macaques

Immunogenicity, safety and tolerability of a recombinant measles-vectored Lassa vaccine: A randomised, placebo-controlled, first-in-human trial

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial

Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-γ-Dependent Innate Immunity

Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression

A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-[gamma]-inducible gbp2 gene

The Stat1 Binding Motif of the Interferon-γ Receptor Is Sufficient to Mediate Stat5 Activation and Its Repression by SOCS3

Phosphorylation of the Stat1 Transactivation Domain Is Required for Full-Fledged IFN-[gamma]-Dependent Innate Immunity

Suchergebnisse filtern